Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis

This data is the supplementary data for a manuscript entitled "Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis". In our study, we showed that dupilumab was an effective and safe treatment choice for children and adolescents with AD. More long-term, high-quality, controlled studies in different regions are in demand for further verification.